Medical Communications

The top ten news stories this week are dominated by corporate scandals, with researchers finding that Coca-Cola paid an organisation …

Humanigen have appointed Timothy E. Morris to its newly created role of Chief Operating Officer and Chief Financial Officer and …

Medipharma has appointed Chris Halyk, the former President of Janssen, to its Board of Directors. This is the third appointment …

Dr Enoch Kariuki has been named as the new Chief Financial Officer at biopharma firm VelosBio, where he will assume …

CAR T cell therapy is one of the latest innovations in gene therapy. The process is primarily used to treat …

The US Government has announced additional funding into Sanofi and GlaxSmithKline’s efforts to develop a recombinant protein-based vaccine to the …

Another week dominated by COVID-19. Among our most popular stories this week, Celltrion’s infliximab biosimilar Remsima has scored approval for …

Japan’s Ministry of Health, Labour and Welfare (MHLW) has sealed a deal with Pfizer and BioNTech to secure 120 million …

Janssen’s IL-12 and IL-23 inhibitor Stelara (ustekinumab) has had its approved indications expanded by the FDA to include the treatment …

NICE has revealed that a combination of Merck KGaA’s Bavencio (avelumab) and Pfizer’s Inlyta (axitinib) will be made available as …

Japan’s biggest drug firm Takeda is said to be mulling plans to cut back its sales operations with a new …

The once-touted COVID cure hydroxychloroquine continues its downward spiral of credibility as new data is published on its lack of …

The antiviral treatment favipiravir, in development from Glenmark Pharma, has shown promise as a potential COVID-19 therapy after hitting its …

Insulin manufacturer Eli Lilly has requested a $24 million tax break over the next 10 years as an investment into …

UCB has revealed promising new data from a head-to-head trial pitting the company’s IL-17A and IL-17F inhibitor bimekizumab against Novartis’ …